Immunomodulatory Gene Therapy Prevents Antibody Formation and Lethal Hypersensitivity Reactions in Murine Pompe Disease
Open Access
- 1 February 2010
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 18 (2), 353-360
- https://doi.org/10.1038/mt.2009.195
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Improved Induction of Immune Tolerance to Factor IX by Hepatic AAV-8 Gene TransferHuman Gene Therapy, 2009
- Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe diseaseGenetics in Medicine, 2009
- Elimination of Antibodies to Recombinant Enzyme in Pompe's DiseaseThe New England Journal of Medicine, 2009
- In vivo and T Cell Cross-Reactivity between Walnut, Cashew and PeanutInternational Archives of Allergy and Immunology, 2008
- Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccinesBlood, 2008
- Reduced α-Gal A enzyme activity in Fabry fibroblast cells and Fabry mice tissues induced by serum from antibody positive patients with Fabry diseaseMolecular Genetics and Metabolism, 2008
- Immune tolerance improves the efficacy of enzyme replacement therapy in canine mucopolysaccharidosis IJCI Insight, 2008
- Ability of Adeno-Associated Virus Serotype 8-Mediated Hepatic Expression of Acid α-Glucosidase to Correct the Biochemical and Motor Function Deficits of Presymptomatic and Symptomatic Pompe MiceHuman Gene Therapy, 2008
- Immune deviation by mucosal antigen administration suppresses gene-transfer–induced inhibitor formation to factor IXBlood, 2006
- Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in LiverMolecular Therapy, 2000